Answers are grounded in this paper and cite their sources.
diagnostics of human T-lymphotropic virus 1 (HTLV-1) remains largely undocumented. This study aimed to map the current landscape of HTLV-1 diagnostics in 13 countries to support the development of World Health Organization guidelines and aid countries in building effective public health responses. Through a review of regulatory records and consultations with government officials, we identified 25 screening assays and three confirmatory tests. While most assays used serum or plasma, two enzyme immunoassays in Brazil were approved for antibody detection in dried blood spots. Only Japan had registered a rapid diagnostic test, which is based on immunochromatography. Screening assays generally had good performance, with both high sensitivity (range: 97.8%-100%) and specificity (range: 99.4%-100%). Assays using dried blood spots also had good performance with 96%-100% sensitivity and 98.7%-99.4% specificity. Three confirmatory, antibody-based tests were identified, but no molecular diagnostic tests were registered. The number of registered screening assays per country varied widely (range: 0-15), revealing a fragmentation and inconsistency in the global market. To foster an effective public health response, expanding access to and uptake of HTLV-1 testing services using accurate and quality-assured products is a priority.
No takes yet. Share an insight, caveat, or question.
Rosadas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: